<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

Head and Neck Cancer

Research    Head and Neck Cancer    Clinical Trials

Research Leading to Clinical Trial Testing Two-Armed Approach to Treating Head and Neck Cancer

A crucial challenge in cancer research is figuring out how to make immunotherapies more effective, channeling, and selectively guiding the body’s own immune responses in targeting and killing tumors.


Author Rachel Sauer | Publish Date September 21, 2021
Full Story

Research    Honors    Head and Neck Cancer    Funding

CU Cancer Center Receives Highly Competitive SPORE Grant for Head and Neck Cancer

Research and treatment of head and neck cancers at the University of Colorado Cancer Center reached a new level this month with a highly competitive Specialized Programs of Research Excellence (SPORE) grant from the National Cancer Institute (NCI). The SPORE was approved by NCI Scientific Program leadership for FY2021 funding; the projected starting date is July 1


Author Greg Glasgow | Publish Date June 07, 2021
Full Story

Research    Head and Neck Cancer

A New Method For Fighting ‘Cold’ Tumors

Not all cancerous tumors are created equal. Some tumors, known as “hot” tumors, show signs of inflammation, which means they are infiltrated with T cells working to fight the cancer. Those tumors are easier to treat, as immunotherapy drugs can then amp up the immune response.


Author Greg Glasgow | Publish Date April 22, 2021
Full Story

Research    Head and Neck Cancer

Inter-campus Collaboration Receives R01 Award to Study Salivary Gland Cancer

Two University of Colorado Cancer Center researchers have received a five-year R01 Award for $497,893 per year from the National Institutes of Health (NIH) to study a potential new drug treatment for salivary gland cancer. The award is part of an inter-campus collaboration between Antonio Jimeno, MD, PhD, co-leader of the Developmental Therapeutics Program, and Tin Tin Su, PhD, co-leader of the Molecular and Cellular Oncology Program.


Author Valerie Gleaton | Publish Date April 16, 2021
Full Story

Research    Head and Neck Cancer

Black Lives Also Matter in Cancer Care

Studies have long reported that Black cancer patients have poorer outcomes than their white counterparts. But two University of Colorado Cancer Center researchers decided to investigate the data further and figure out why. What they found was that the outcome disparity was caused not by biology, but simply by differences in access to health care.


Author Cancer Center | Publish Date October 01, 2020
Full Story

Research    Head and Neck Cancer    Cancer    Clinical Trials

CU Cancer Center Study Aims to Increase Access to Head and Neck Cancer Clinical Trials in Hispanic Population

Nearly two thousand people living in Colorado will be diagnosed with head and neck cancer (HNC) in 2020. Generally, a very aggressive disease, head and neck cancer require expert care that is not widely available in community cancer clinics. However, patients that are not well-represented in clinical studies, especially Hispanic patients, are less likely to get care from centers that specialize in the disease, such as the University of Colorado Cancer Center.


Author Cancer Center | Publish Date June 29, 2020
Full Story

Research    Faculty    Head and Neck Cancer

Improving Humanized Mouse Models for Head and Neck Cancer Research

If a new anti-cancer drug shows promise in a Petri dish, often the next step is to test the drug’s effect in mice. This system tends to work well with drugs that directly target cancer, but breaks down with immunotherapies. That’s because tumors from human cancer samples can only grow in mice with suppressed immune systems. Immunotherapies activate the immune system against cancer. And in a mouse model in which the immune system has been suppressed, there is no immune system to activate against cancer.


Author Garth Sundem | Publish Date August 23, 2018
Full Story

Research    Head and Neck Cancer

Grape Seed Extract Kills Head and Neck Cancer Cells, Leaves Healthy Cells Unharmed

Nearly 12,000 people will die of head and neck cancer in the United States this year and worldwide cases will exceed half a million.


Author Garth Sundem | Publish Date January 26, 2012
Full Story

CU Cancer Center In the News

The Denver Post

Wings of Hope Raises More than $100,000 for Pancreatic Cancer Research at CU Cancer Center

news outletThe Denver Post
Publish DateOctober 05, 2021

Despite the continuing effects of COVID-19, a dedicated community of supporters converged Sept. 18 for the sold-out Evening of Hope, generating more than $100,000 to benefit pancreatic cancer research at the University of Colorado Cancer Center.

Full Story
Denver 7

Robotic Technology Takes Us into a New Era of Drug Discovery

news outletDenver 7
Publish DateSeptember 30, 2021

A giant robot at CU Anschutz Medical Campus is busy doing lifesaving work. Dan LaBarbera is the founding director at the Center for Drug Discovery at the campus.

Full Story
Healio

Animal imaging researcher wins award for contribution to oncology research

news outletHealio
Publish DateAugust 04, 2021

The International Society of Magnetic Resonance in Medicine awarded Natalie J. Serkova, the 2021 Senior Fellow Award for her work in animal imaging for oncology research. “I was humbled and ecstatic to receive this award…,” Serkova, director of the Animal Imaging Shared Resource at University of Colorado Cancer Center, said during an interview with Healio.

Full Story
Cure Today

Life With von Hippel-Lindau Disease

news outletCure Today
Publish DateAugust 03, 2021

At first, Camron King’s sixth-grade teacher thought he was nervous. King had just started at a new school when he told the teacher he couldn’t read aloud from his textbook. The problem, however, was more complicated than childhood stage fright.

Full Story